Cumberland Pharma's Q4 Loss Narrows as Talicia Drives Sales Growth Amid Strong Revenue Surge | MarketWire

Cumberland Pharmaceuticals saw Q4 losses narrow as sales jumped 31%, driven by Vibativ, Sancuso, and Talicia.